The benefits and harms of breast cancer screening: an independent review
A partir d'une revue de la littérature, ce rapport d'un comité d'experts indépendants analyse la controverse concernant les bénéfices et les risques associés au dépistage organisé triennal du cancer du sein au Royaume-Uni chez les femmes âgées de 50 à 70 ans
The breast cancer screening programmes in the United Kingdom currently invite women aged 50–70 years for screening mammography every 3 years. Since the time the screening programmes were established, there has been debate, at times sharply polarised, over the magnitude of their benefit and harm, and the balance between them. The expected major benefit is reduction in mortality from breast cancer. The major harm is overdiagnosis and its consequences; overdiagnosis refers to the detection of cancers on screening, which would not have become clinically apparent in the woman’s lifetime in the absence of screening.
British Journal of Cancer , article en libre accès, 2012